Voloridge Investment Management’s Apellis Pharmaceuticals APLS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $8.11M | Buy |
468,710
+214,920
| +85% | +$3.72M | 0.03% | 611 |
|
|
2025
Q1 | $5.55M | Sell |
253,790
-92,095
| -27% | -$2.01M | 0.02% | 746 |
|
|
2024
Q4 | $11M | Sell |
345,885
-468,679
| -58% | -$15M | 0.04% | 544 |
|
|
2024
Q3 | $23.5M | Buy |
814,564
+125,456
| +18% | +$3.62M | 0.09% | 327 |
|
|
2024
Q2 | $26.4M | Buy |
+689,108
| New | +$26.4M | 0.1% | 288 |
|
|
2023
Q4 | – | Sell |
-54,263
| Closed | -$2.06M | – | 1149 |
|
|
2023
Q3 | $2.06M | Sell |
54,263
-89,139
| -62% | -$3.39M | 0.01% | 910 |
|
|
2023
Q2 | $13.1M | Buy |
143,402
+77,167
| +117% | +$7.03M | 0.06% | 394 |
|
|
2023
Q1 | $4.37M | Buy |
+66,235
| New | +$4.37M | 0.02% | 711 |
|
|
2022
Q4 | – | Sell |
-107,452
| Closed | -$7.34M | – | 1417 |
|
|
2022
Q3 | $7.34M | Buy |
+107,452
| New | +$7.34M | 0.04% | 535 |
|
|
2022
Q2 | – | Sell |
-73,426
| Closed | -$3.73M | – | 1414 |
|
|
2022
Q1 | $3.73M | Sell |
73,426
-2,736
| -4% | -$139K | 0.02% | 741 |
|
|
2021
Q4 | $3.6M | Sell |
76,162
-272,546
| -78% | -$12.9M | 0.02% | 837 |
|
|
2021
Q3 | $11.5M | Buy |
348,708
+193,909
| +125% | +$6.39M | 0.07% | 390 |
|
|
2021
Q2 | $9.78M | Buy |
+154,799
| New | +$9.78M | 0.07% | 417 |
|
|
2021
Q1 | – | Sell |
-7,901
| Closed | -$452K | – | 1371 |
|
|
2020
Q4 | $452K | Buy |
+7,901
| New | +$452K | ﹤0.01% | 1146 |
|
|
2020
Q1 | – | Sell |
-16,762
| Closed | -$513K | – | 1074 |
|
|
2019
Q4 | $513K | Buy |
+16,762
| New | +$513K | 0.01% | 810 |
|
|
2019
Q2 | – | Sell |
-11,798
| Closed | -$230K | – | 746 |
|
|
2019
Q1 | $230K | Buy |
+11,798
| New | +$230K | 0.01% | 864 |
|